Whoop, which makes a fitness tracker and sells a subscription-based health coaching app, raises $200M from SoftBank's Vision Fund 2 at a valuation of $3.6B
Funding enables fitness tracker start-up to challenge tech giants in health monitoring business — Whoop, which makes a fitness tracker … Tweets: @dangraziano , @epaley , @micahjay1 , @scottbelsky , and @willahmed Tweets: Dan Graziano / @dangraziano : Wow! Seems extremely overvalued considering Fitbit sold to Google for 2.1B (a ~600M premium over it's market valuation) and has at least 29M active users and 500,000 paying Premium subscribers. I'm curious how many users Whoop has. They refuse to say... https://twitter.com/... Eric Paley / @epaley : Huge congratulations to you and the team Will for what you and the Whoop team have built and the many many people who benefit every day! https://twitter.com/... Micah Rosenbloom / @micahjay1 : Congrats to @willahmed and @whoop for insights around rest, recovery and performance - so much more to come. https://twitter.com/... Scott Belsky / @scottbelsky : Incredible to watch @willahmed & @whoop team push product and UX to help all of us push ourselves, and in the process bring the whole category to another level. It has been a wild journey, yet still early days... 💥 https://twitter.com/... Will Ahmed / @willahmed : BREAKING: @whoop has closed 200m Series F led by @SoftBank_Group. I am so grateful to Whoop members around the world who share our mission to unlock human performance. https://www.ft.com/...
Context & Ripple Effects
Whoop's raise caps a fast escalation: a $25M Series C in 2018, a $55M Series D in late 2019, then a $100M round at a $1.2B valuation just ten months ago. SoftBank Vision Fund 2 leading this $200M at $3.6B nearly triples that price inside a year.
The skepticism in the immediate reaction is about unit opacity: Dan Graziano notes Whoop won't disclose users while Fitbit fetched $2.1B with tens of millions of actives and paying Premium subscribers. What followed vindicated part of the bet — Whoop went on to a $575M raise at $10.1B with $1B in ARR, and by mid-2026 both Whoop and Oura were eyeing IPOs even as investors stayed wary of hardware margins.
First-order effects
- Whoop gets the war chest its FT framing says is meant to challenge tech giants in health monitoring — directly against Google, which owns Fitbit, and Apple's watch business, without naming user counts to defend the price.
- SoftBank's Vision Fund 2 takes a marquee consumer-health position at a $3.6B entry, doubling down on the subscription-plus-hardware model rather than pure device economics.
Second-order effects
- Fitbit under Google faces a rival whose revenue is anchored in recurring coaching subscriptions rather than discounted trackers — pressuring Google to decide whether Premium-style services or device pricing is its answer.
- Oura and other screenless-band competitors inherit a higher fundraising benchmark: Whoop's tripling valuation resets what a health-wearable startup can claim in its next round.
Third-order effects
- If Whoop's arc holds — from $1.2B to a reported $10.1B and $1B ARR en route to an IPO — wearables consolidate around subscription-locked ecosystems, with hardware sold near cost as an access fee to recurring health data.
- The pattern also sharpens the investor debate the WSJ flagged: consumer hardware's low margins push wearable companies toward software-like valuations, making disclosed subscriber metrics the real test of who deserves them.
The trend: Health wearables are repricing from hardware companies into subscription platforms, with Whoop's funding trajectory — and eventual IPO path alongside Oura — setting the sector's template.